PANcreatic CAncer Initial Detection via liquid biopsy

Artificial intelligence may be redefining how we diagnose and treat cancer, but how close are we to bringing these innovations into clinical practice?

In this joint webinar, three leading EU-funded projects – PHIRE, PANCAIM, and PANCAID – came together to explore the transformative role of AI in oncology. Moderated by Federica Zanca, EIC Programme Manager for Medical Imaging and AI in Healthcare, the session brought together experts from across Europe to discuss how data, algorithms, and collaboration can drive earlier and more precise cancer diagnosis.

The panel featured:

• John Hermans, Radboud University Medical Center, Co-Coordinator of PANCAIM
• Massimo Alfano, Group Leader at San Raffaele Biomedical Science Park and Coordinator of the PHIRE Project
• Núria Malats, Head of the Genetic and Molecular Epidemiology Group at CNIO and PANCAID’s Work Package 3 Lead

The discussion explored:

• How AI supports early detection and risk prediction in cancer
• What clinicians can learn from AI that may not be visible to the human eye
• The role of large and diverse datasets and the challenges of building them
• How synthetic data can complement real-world data
• What’s needed to move AI-driven cancer diagnostics from research to the clinic

This exchange highlighted the value of collaboration across disciplines and projects — showing how joint efforts can bring us closer to making precision oncology a European reality.

🎥 Watch the full webinar recording here.

Artificial intelligence (AI) is rapidly transforming cancer research and clinical care, offering powerful tools for early detection and precision oncology.

In our latest PANCAID Masterclass, Dr Núria Malats and Sergio Sabroso from CNIO explore how AI is advancing pancreatic cancer research, with a focus on pancreatic ductal adenocarcinoma (PDAC).

This lecture covers:

• Core definitions and applications of AI in cancer research
• Input tools and data modalities, from radiomics to pathomics
• Synthetic data and image generation
• AI-driven integration of liquid biopsy features
• Future perspectives for clinical implementation

The session provides an accessible introduction for cancer researchers, clinicians, and students interested in how data-driven approaches are shaping the future of oncology.

👉 Watch the full Masterclass here.

We’re thrilled to announce that in just a few weeks, the PANCAID team will come together in beautiful Brussels, Belgium, for our 4th General Assembly and 3rd Annual Cluster Meeting!
It will be a few days dedicated to advancing our research, sharing insights, connecting across projects, and shaping the path forward together.